These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9707134)

  • 1. Meningococcal vaccination.
    Treadwell TL
    JAMA; 1998 Aug; 280(6):515-6. PubMed ID: 9707134
    [No Abstract]   [Full Text] [Related]  

  • 2. Meningococcal disease: was Ottawa's mass-vaccination program necessary?
    Gray C
    CMAJ; 1992 Mar; 146(6):1033, 1036-7. PubMed ID: 1544060
    [No Abstract]   [Full Text] [Related]  

  • 3. Meningococcal disease and public health practice: a complicated road map.
    Moore KA; Osterholm MT
    JAMA; 1998 Feb; 279(6):472-3. PubMed ID: 9466643
    [No Abstract]   [Full Text] [Related]  

  • 4. Statement on meningococcal vaccination for travellers. Committee to Advise on Tropical Medicine and Travel.
    CMAJ; 1995 Aug; 153(3):303-8. PubMed ID: 7614446
    [No Abstract]   [Full Text] [Related]  

  • 5. Preventing meningococcal infection in college students.
    Harrison LH
    Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Guidelines for controlling meningococcal disease.
    CMAJ; 1992 Mar; 146(6):939-42, 945-8. PubMed ID: 1544081
    [No Abstract]   [Full Text] [Related]  

  • 7. [Anti-meningococcal polysaccharide vaccines].
    Gómez JA; Ferreirós CM; Criado MT
    Enferm Infecc Microbiol Clin; 1997; 15(7):347-8. PubMed ID: 9410045
    [No Abstract]   [Full Text] [Related]  

  • 8. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

  • 9. Vaccine research: new vaccines and evidence of vaccine safety.
    Commun Dis Rep CDR Wkly; 1999 May; 9(19):167, 170. PubMed ID: 10334064
    [No Abstract]   [Full Text] [Related]  

  • 10. Availability of meningococcal vaccine in single-dose vials for travelers and high-risk persons.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 Oct; 39(42):763. PubMed ID: 2120575
    [No Abstract]   [Full Text] [Related]  

  • 11. Meningococcal vaccine trial in Norway.
    Fine PE
    Lancet; 1991 Dec; 338(8780):1456-7. PubMed ID: 1683438
    [No Abstract]   [Full Text] [Related]  

  • 12. First phase of group C meningococcal vaccination programme to start in November.
    Commun Dis Rep CDR Wkly; 1999 Oct; 9(44):387, 390. PubMed ID: 10560173
    [No Abstract]   [Full Text] [Related]  

  • 13. Meningococcal infections in Quebec--1991-92.
    Lavigne P; Boulianne N; Fortin C; Naccache H; Douville-Fradet M
    Can Commun Dis Rep; 1992 Aug; 18(15):113-6. PubMed ID: 1290994
    [No Abstract]   [Full Text] [Related]  

  • 14. Meningococcal disease in Delhi.
    Taneja A
    Indian Pediatr; 1985 Mar; 22(3):181-4. PubMed ID: 4030053
    [No Abstract]   [Full Text] [Related]  

  • 15. [Meningococcal infections: vaccination and prevention by drugs].
    Herzog C
    Ther Umsch; 1983 Mar; 40(3):239-43. PubMed ID: 6407135
    [No Abstract]   [Full Text] [Related]  

  • 16. Meningococcal vaccine in sub-Saharan Africa.
    Perkins BA; Broome CV; Rosenstein NE; Schuchat A; Reingold AL
    Lancet; 1997 Dec; 350(9092):1708; author reply 1709-10. PubMed ID: 9400540
    [No Abstract]   [Full Text] [Related]  

  • 17. Meningococcal vaccine in sub-Saharan Africa.
    Kaninda AV; Varaine F; Henkens M; Paquet C
    Lancet; 1997 Dec; 350(9092):1708. PubMed ID: 9400541
    [No Abstract]   [Full Text] [Related]  

  • 18. Meningococcal disease in Newfoundland, 1967-1991.
    Can Commun Dis Rep; 1992 Aug; 18(15):116-7. PubMed ID: 1290995
    [No Abstract]   [Full Text] [Related]  

  • 19. [Serologic evaluation of the efficiency of meningococcal capsular polysaccharide vaccines of serogroups A and C: correlation with age, dosage, previous immune status and serological assays].
    Veronesi R; Fayet MT; Stellmann C; Takeda AK; Feldman C; Focaccia R; Mazza CC; Oliveira CE; Sebe E; Adelino M; Diniz JM; Zuccas WA
    Rev Hosp Clin Fac Med Sao Paulo; 1977; 32(5):296-305. PubMed ID: 392678
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring the impact of the serogroup C meningococcal conjugate vaccination programme.
    Commun Dis Rep CDR Wkly; 1999 Dec; 9(49):435, 438. PubMed ID: 10598397
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.